Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1996
10/30/1996EP0739335A1 Pyrrolidine-containing monomers and oligomers
10/30/1996EP0739210A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
10/30/1996EP0739202A1 Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
10/30/1996EP0739200A1 Therapeutic substituted guanidines
10/30/1996EP0695301B1 Indole derivatives as 5-ht1-like agonists for use in migraine
10/30/1996EP0532595B1 The pharmacological use of certain cystine derivatives
10/30/1996EP0527852B1 Method and compositions for treating injury
10/30/1996EP0512071B1 Method and compositions for inhibiting angiogenesis
10/30/1996CN1134706A Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
10/30/1996CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
10/30/1996CN1134699A Succinamic acid compound, process for producing the same, and use thereof
10/30/1996CN1134670A Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
10/30/1996CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM
10/30/1996CN1134665A Novel pharmaceutical composition containing the ACE inhibitor ramipril and a dihydropyridine compound
10/30/1996CN1134664A Process for preparing a clodronate preparation
10/30/1996CN1134421A Substituted thiophenesulfonylureas and-thioureas, processes for their preparation, their use as medicament or diagnostic, and medicament containing them
10/30/1996CN1134417A 2,8-disubstituted quinazolinones
10/30/1996CN1134413A 4-Mercaptobenzoylguanidine derivatives
10/29/1996US5569768 Angiotensin II antagonists
10/29/1996US5569764 N-benzyl dihydroindole LTD4 antagonists
10/29/1996US5569759 Water soluble texaphyrin metal complex preparation
10/29/1996US5569741 Cyclic octapeptide neuromedin B receptor antagonists
10/29/1996US5569675 Administering to treat blood disorders
10/29/1996US5569669 Treating anxiety, depression
10/29/1996US5569665 Peptidyl derivatives and their use as metalloproteinases inhibitors
10/29/1996US5569663 Use of a spin trap in a cosmetic or dermatological composition
10/29/1996US5569658 Tricyclic derivatives
10/29/1996US5569648 Administering insulin-like growth factor
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/29/1996CA1338683C Fatty acid therapy and compositions
10/24/1996WO1996033285A1 Efflux pump inhibitors
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033194A1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
10/24/1996WO1996033192A1 Benzimidazole compounds and their use as modulators of the gabaa receptor complex
10/24/1996WO1996033191A1 Benzimidazole compounds and their use as modulators of the gabaa receptor complex
10/24/1996WO1996033187A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
10/24/1996WO1996033184A1 Thf-containing sulfonamide inhibitors of aspartyl protease
10/24/1996WO1996033181A1 Ethynylthiazole derivative
10/24/1996WO1996033175A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
10/24/1996WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
10/24/1996WO1996033170A1 N-aroylamino acid amides as endothelin inhibitors
10/24/1996WO1996033166A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors
10/24/1996WO1996033165A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
10/24/1996WO1996033161A1 Derivatives of succinamide and their use as metalloproteinase inhibitors
10/24/1996WO1996033159A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996WO1996032966A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996WO1996032964A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
10/24/1996WO1996032961A1 Compositions and methods for regulating hair growth
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032954A1 Nitrosylated neuropeptides
10/24/1996WO1996032946A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
10/24/1996WO1996032939A1 USE OF α1L AGONISTS IN THE TREATMENT OF INCONTINENCE
10/24/1996WO1996032937A1 Benzothiophenes with novel basic side chains
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists
10/24/1996WO1996023769A3 Heterocyclic compounds possessing 5ht2c receptor antagonist activity
10/24/1996DE19514579A1 Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz Using alpha¶1¶¶L¶ agonists for treating urinary incontinence
10/24/1996CA2218716A1 N-aroylamino acid amides as endothelin inhibitors
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2218597A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996CA2218380A1 Novel hydroxamic and carbocylic acids as metalloprotease inhibitors
10/24/1996CA2217865A1 Efflux pump inhibitors
10/24/1996CA2216882A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
10/24/1996CA2215902A1 Benzothiophenes with novel basic side chains
10/24/1996CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions
10/23/1996EP0738727A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
10/23/1996EP0738725A2 Benzothiophenes with novel basic side chains
10/23/1996EP0738721A1 Forms a and b of n-[[[2-[[[2-[(diaminomethylen)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylen]-4-bromobenzenosulphonamide
10/23/1996EP0738717A1 Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines
10/23/1996EP0738715A2 Arylalkyl-pyridazinones
10/23/1996EP0738714A2 Process for preparing new fibrinogen receptor antagonists
10/23/1996EP0738512A1 Use of a HMG CoA reductase inhibitor to prevent a second heart attack
10/23/1996EP0738510A2 Use of an HMG-CoA reductase as anti-ageing agent
10/23/1996EP0738475A1 Alpha-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/23/1996EP0738280A1 Superactive vip antagonists
10/23/1996EP0738273A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
10/23/1996EP0738269A1 Novel piperidine derivatives with paf antagonist activity
10/23/1996EP0738262A1 Novel heterocyclic compounds
10/23/1996EP0738156A1 Methods and compositions for inhibiting thrombogenesis
10/23/1996EP0738155A1 Modular design and synthesis of oxazolone-derived molecules
10/23/1996EP0738150A1 Bicyclic fibrinogen antagonists
10/23/1996EP0738149A1 1-aminoindan derivatives and compositions thereof
10/23/1996EP0738145A1 Pharmaceutical compositions
10/23/1996EP0738144A1 Phenylmethyl hexanamides, and the use thereof
10/23/1996EP0738143A1 Curcumin, analogues of curcumin and novel uses thereof
10/23/1996EP0738107A1 Inhibitors of fatty acid synthesis as antimicrobial agents
10/23/1996EP0646110B1 N-substituted 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents
10/23/1996EP0640143A4 Senescent cell derived inhibitors of dna synthesis.
10/23/1996EP0600950B1 Amide tetrazole acat inhibitors
10/23/1996CN1134155A Androstenones
10/23/1996CN1134153A Matrix metalloprotease inhibitors
10/23/1996CN1134151A Pyrazine carboxamide derivs., their production and their use in medicaments
10/23/1996CN1134150A Quinazoline deriv.
10/23/1996CN1134149A Phenylindole compounds
10/23/1996CN1134110A Method for regulating gastrointestinal motility
10/23/1996CN1134107A Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/23/1996CN1133844A Osa-or thia-aliphatically bridged quinoxaline-2,3-diones
10/23/1996CN1133840A Indolepiperidine derivatives
1 ... 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 ... 1564